ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,323,340 | -13.0% | 63,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,520,825 | +27.3% | 63,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,195,070 | +18.2% | 63,500 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $1,010,920 | +54.6% | 63,500 | +58.8% | 0.00% | 0.0% |
| Q3 2022 | $654,000 | -67.2% | 40,000 | -71.7% | 0.00% | -60.0% |
| Q2 2022 | $1,994,000 | +105.8% | 141,470 | +253.7% | 0.01% | +150.0% |
| Q1 2022 | $969,000 | +39.4% | 40,000 | +34.3% | 0.00% | +100.0% |
| Q4 2021 | $695,000 | -54.9% | 29,780 | -50.1% | 0.00% | -66.7% |
| Q1 2021 | $1,540,000 | -76.2% | 59,702 | -50.6% | 0.00% | -80.0% |
| Q4 2020 | $6,460,000 | +24.0% | 120,839 | -4.3% | 0.02% | +15.4% |
| Q3 2020 | $5,210,000 | +540.8% | 126,278 | +653.3% | 0.01% | +550.0% |
| Q2 2020 | $813,000 | +34.6% | 16,763 | +17.3% | 0.00% | 0.0% |
| Q1 2020 | $604,000 | – | 14,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |